Lantern Pharma Inc. (LTRN)
Lantern Pharma Statistics
Share Statistics
Lantern Pharma has 10.78M shares outstanding. The number of shares has increased by 0.24% in one year.
| 10.78M |
| 0.24% |
| 0% |
| 23.23% |
| n/a |
| 1,100 |
| 2.4% |
Short Selling Information
The latest short interest is 254.84K, so 2.36% of the outstanding shares have been sold short.
| 254.84K |
| 2.36% |
| 2.68% |
| 5.48 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Lantern Pharma.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 0.01, with a Debt / Equity ratio of 0.
| 0.01 |
| 0.01 |
| 0 |
| -0.01 |
| -0.01 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-865,883,875 |
| 24 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -42.17% in the last 52 weeks. The beta is 1.54, so Lantern Pharma's price volatility has been higher than the market average.
| 1.54 |
| -42.17% |
| 3.45 |
| 3.72 |
| 50.4 |
| 45,790 |
Balance Sheet
The company has 7.51M in cash and 243.66K in debt, giving a net cash position of 7.27M.
| 7.51M |
| 243.66K |
| 7.27M |
| -76.03B |
| 21.1M |
| 16.54M |
Cash Flow
In the last 12 months, operating cash flow was -17.81M and capital expenditures -12.6K, giving a free cash flow of -17.83M.
| -17.81M |
| -12.6K |
| -17.83M |
| -1.66 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
LTRN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for LTRN is $25, which is 644% higher than the current price. The consensus rating is "Buy".
| $25 |
| 644% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -3.21 |
| 2 |